Cargando…

Modulation of HLA-DR in dry eye patients following 30 days of treatment with a lubricant eyedrop solution

PURPOSE: To determine the changes in dry eye disease (DED) severity and the percentage of cells expressing HLA-DR on the ocular surface following treatment with lubricant eyedrops containing polyethylene glycol and propylene glycol (PEG/PG) and the gelling agent hydroxypropyl guar (HP-Guar). PATIENT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandez, Karen B, Epstein, Seth P, Raynor, Geoffrey S, Sheyman, Alan T, Massingale, Morgan L, Dentone, Peter G, Landegger, Lukas D, Asbell, Penny A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485852/ https://www.ncbi.nlm.nih.gov/pubmed/26170605 http://dx.doi.org/10.2147/OPTH.S81355

Ejemplares similares

Effect of Refresh Plus(®) preservative-free lubricant eyedrops on tear ferning patterns in dry eye and normal eye subjects
por: Alanazi, Saud A, et al.
Publicado: (2019)

Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study
por: Labetoulle, Marc, et al.
Publicado: (2018)

Conjunctival HLA-DR Expression and Its Association With Symptoms and Signs in the DREAM Study
por: Roy, Neeta S., et al.
Publicado: (2019)

Effect of Autologous Serum Eyedrops on Ocular Surface Disease Caused by Preserved Glaucoma Eyedrops
por: So, Ha-Rim, et al.
Publicado: (2020)

Allogeneic Umbilical Cord Plasma Eyedrops for the Treatment of Recalcitrant Dry Eye Disease Patients
por: Wong, Joy, et al.
Publicado: (2023)

Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye
por: Deveney, Tatiana, et al.
Publicado: (2018)

Assessing the Quality, Reliability, and Readability of Online Information on Dry Eye Disease
por: Oydanich, Marko, et al.
Publicado: (2022)

Dry Eye Subtypes in the Dry Eye Assessment and Management (DREAM) Study: A Latent Profile Analysis
por: Yu, Kimberley, et al.
Publicado: (2022)

Trehalose/hyaluronate eyedrop effects on ocular surface inflammatory markers and mucin expression in dry eye patients
por: Fariselli, Chiara, et al.
Publicado: (2018)

Prevention of Surgery-Induced Dry Eye by Diquafosol Eyedrops after Femtosecond Laser-Assisted Cataract Surgery
por: Yamazaki, Kenichiro, et al.
Publicado: (2022)

Association of Ocular Surface Immune Cells With Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study
por: Kuklinski, Eric J., et al.
Publicado: (2023)

The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research
por: Roy, Neeta S., et al.
Publicado: (2017)

Corneal permeability changes in dry eye disease: an observational study
por: Fujitani, Kenji, et al.
Publicado: (2016)

Age Associations with Dry Eye Clinical Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study
por: Zhao, Megan, et al.
Publicado: (2023)

Delineation of LASIK Flaps with Prednisolone Acetate Eyedrops
por: Fahd, Daoud C, et al.
Publicado: (2014)

Hirsutism following the use of bimatoprost eyedrops for glaucoma
por: Kaliaperumal, Subashini, et al.
Publicado: (2014)

Allergic contact dermatitis caused by dorzolamide eyedrops
por: Lee, Seung-Jun, et al.
Publicado: (2015)

Clinical Efficacy, Tolerability and Safety of a New Multiple-Action Eyedrop in Subjects with Moderate to Severe Dry Eye
por: Roszkowska, Anna Maria, et al.
Publicado: (2022)

Defining the needs and preferences of patients with dry eye disease
por: Asbell, Penny, et al.
Publicado: (2019)

Association of Tear Osmolarity With Signs and Symptoms of Dry Eye Disease in the Dry Eye Assessment and Management (DREAM) Study
por: Greiner, Jack V., et al.
Publicado: (2023)

Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15
por: Enz, Lukas Simon, et al.
Publicado: (2019)

A randomized multicenter study comparing seawater washes and carmellose artificial tears eyedrops in the treatment of dry eye syndrome
por: Diaz-Llopis, Manuel, et al.
Publicado: (2019)

Clinical Efficacy of an Eyedrop Containing Hyaluronic Acid and Ginkgo Biloba in the Management of Dry Eye Disease Induced by Cataract Surgery
por: Fogagnolo, Paolo, et al.
Publicado: (2022)

Topical Omega-3 Fatty Acids Eyedrops in the Treatment of Dry Eye and Ocular Surface Disease: A Systematic Review
por: Paik, Benjamin, et al.
Publicado: (2022)

Contamination of multi dose eyedrops in the intra and perioperative context
por: Daehn, Tristan, et al.
Publicado: (2021)

Is it time for a moratorium on the use of benzalkonium chloride in eyedrops?
por: D'andrea, Luca, et al.
Publicado: (2022)

Fluorophotometry as a diagnostic tool for the evaluation of dry eye disease
por: Fahim, Magid M, et al.
Publicado: (2006)

A randomized crossover study comparing trehalose/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndrome
por: Pinto-Bonilla, Juan Carlos, et al.
Publicado: (2015)

Lifitegrast Ophthalmic Solution 5% Is a Safe and Efficient Eyedrop for Dry Eye Disease: A Systematic Review and Meta-Analysis
por: Li, Jing-Xing, et al.
Publicado: (2022)

Tear Proteomics Approach to Distinguishing Primary from Secondary Sjögren’s Syndrome for Dry Eye Patients with Long-Term Instillation of Eyedrops
por: Hsiao, Yu-Ting, et al.
Publicado: (2022)

Tear Film Stabilization and Symptom Improvement in Dry Eye Disease: The Role of Hyaluronic Acid and Trehalose Eyedrops versus Carmellose Sodium
por: Sánchez-González, José-María, et al.
Publicado: (2023)

Comparing the needs and preferences of patients with moderate and severe dry eye symptoms across four countries
por: Messmer, Elisabeth, et al.
Publicado: (2019)

Contribution of Tin to the Strain Hardening of Self-Lubricating Sintered Al-30Sn Alloy and Its Wear Resistance under Dry Friction
por: Rusin, Nikolay M., et al.
Publicado: (2023)

HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules
por: Denzin, Lisa K., et al.
Publicado: (1996)

Association of HLA-DR1, HLA-DR13, and HLA-DR16 Polymorphisms with Systemic Lupus Erythematosus: A Meta-Analysis
por: Wang, Tingrui, et al.
Publicado: (2022)

Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation
por: Ballou, Cassandra, et al.
Publicado: (2023)

Cyclosporine A eyedrops with self-nanoemulsifying drug delivery systems have improved physicochemical properties and efficacy against dry eye disease in a murine dry eye model
por: Bang, Seung Pil, et al.
Publicado: (2019)

HLA-DM Captures Partially Empty HLA-DR Molecules for Catalyzed Peptide Removal
por: Anders, Anne-Kathrin, et al.
Publicado: (2010)

Effect of long-term treatment with eyedrops for glaucoma on conjunctival bacterial flora
por: Honda, Rio, et al.
Publicado: (2011)

Corneal Epithelial Wound Healing Promoted by Verbascoside-Based Liposomal Eyedrops
por: Ambrosone, Luigi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sr57irfvdu2b1lv3mj1buanrcl